HomeIMVT • NASDAQ
add
Immunovant Inc
Previous close
$26.54
Day range
$26.58 - $27.01
Year range
$24.61 - $45.58
Market cap
3.94B USD
Avg Volume
830.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 115.74M | 87.29% |
Net income | -109.12M | -86.01% |
Net profit margin | — | — |
Earnings per share | -0.74 | -64.44% |
EBITDA | -115.65M | -87.31% |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 472.94M | 75.21% |
Total assets | 515.71M | 76.57% |
Total liabilities | 66.65M | 65.56% |
Total equity | 449.05M | — |
Shares outstanding | 146.78M | — |
Price to book | 8.67 | — |
Return on assets | -52.35% | — |
Return on capital | -58.23% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -109.12M | -86.01% |
Cash from operations | -88.65M | -47.60% |
Cash from investing | -196.00K | -476.47% |
Cash from financing | 730.00K | 393.24% |
Net change in cash | -87.06M | -45.03% |
Free cash flow | -43.49M | -8.49% |
About
Founded
2018
Website
Employees
207
